These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31263193)

  • 1. Transcellular transfer of nanomedicine.
    Jang HL; Sengupta S
    Nat Nanotechnol; 2019 Aug; 14(8):731-732. PubMed ID: 31263193
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis.
    Posadas I; Monteagudo S; Ceña V
    Nanomedicine (Lond); 2016 Apr; 11(7):833-49. PubMed ID: 26980585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of Nanomaterial/Nanomedicine Trafficking in Vivo.
    Wang L; Yan L; Liu J; Chen C; Zhao Y
    Anal Chem; 2018 Jan; 90(1):589-614. PubMed ID: 29155562
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging-guided revival of nanomedicine?
    Senders ML; Fayad ZA; Reiner T; Mulder WJ; Pérez-Medina C
    Nanomedicine (Lond); 2017 Jan; 12(2):89-90. PubMed ID: 27876441
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 6. Theranostic nanomedicine for cancer.
    Sumer B; Gao J
    Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcytosis of Nanomedicine for Tumor Penetration.
    Liu Y; Huo Y; Yao L; Xu Y; Meng F; Li H; Sun K; Zhou G; Kohane DS; Tao K
    Nano Lett; 2019 Nov; 19(11):8010-8020. PubMed ID: 31639306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging trend of advanced image analysis in nanomedicine.
    Bhattacharjee S
    Nanomedicine (Lond); 2015; 10(18):2801-4. PubMed ID: 26377154
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer nanomedicine: addressing the dark side of the enhanced permeability and retention effect.
    Huynh E; Zheng G
    Nanomedicine (Lond); 2015; 10(13):1993-5. PubMed ID: 26096565
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nanomedicine: chance or risk for the patients?].
    Kathmann W
    Dtsch Med Wochenschr; 2009 May; 134(19):p19. PubMed ID: 19424944
    [No Abstract]   [Full Text] [Related]  

  • 14. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance?
    Mercado-Lubo R; McCormick BA
    Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
    Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
    Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for multimodality treatment of cancer.
    Mi Y; Guo Y; Feng SS
    Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
    [No Abstract]   [Full Text] [Related]  

  • 19. New Strategies in Cancer Nanomedicine.
    Tong R; Kohane DS
    Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.
    Muthu MS; Singh S
    Nanomedicine (Lond); 2009 Jan; 4(1):105-18. PubMed ID: 19093899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.